Dayna Terrazas

Long-term Outcomes after Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (ADA SCID).

Aaron M. Rosenfeld, F. Bushman, K. Cornetta, 2021, Blood.

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

K. Cornetta, M. Hershfield, G. Crooks, 2021, The New England journal of medicine.

Lentiviral gene therapy for X-linked chronic granulomatous disease

Luca Biasco, Adrian J. Thrasher, David A. Williams, 2020, Nature Medicine.

Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency

Barbara Engel, John Tse, David Gjertson, 2017, The Journal of clinical investigation.

Findings on Optical Coherence Tomography in Malignant Infantile Osteopetrosis.

D. Kohn, I. Tsui, Grace Choi, 2022, Ophthalmic surgery, lasers & imaging retina.

Lentiviral gene therapy for X-linked chronic granulomatous disease

David A. Williams, Leo D. Wang, F. Bushman, 2020, Nature Medicine.